We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$31.3B
AUM Growth
+$1.67B
Cap. Flow
+$1.83B
Cap. Flow %
5.84%
Top 10 Hldgs %
37.77%
Holding
1,441
New
112
Increased
695
Reduced
355
Closed
81

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$698M
2
NFLX icon
Netflix
NFLX
+$243M
3
VTR icon
Ventas
VTR
+$232M
4
META icon
Meta Platforms (Facebook)
META
+$184M
5
AMZN icon
Amazon
AMZN
+$153M

Sector Composition

Rank Sector Weight
1 Technology 30.75%
2 Real Estate 25.79%
3 Communication Services 11.7%
4 Consumer Discretionary 7.26%
5 Financials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOSS icon
1301
Gossamer Bio
GOSS
$100M
$2K ﹤0.01%
+771
New +$2.2K
IRWD icon
1302
Ironwood Pharmaceuticals
IRWD
$626M
$2K ﹤0.01%
573
IVVD icon
1303
Invivyd
IVVD
$175M
$2K ﹤0.01%
+923
New +$1.92K
KALV
1304
DELISTED
KalVista Pharmaceuticals
KALV
$2K ﹤0.01%
154
LXEO icon
1305
Lexeo Therapeutics
LXEO
$345M
$2K ﹤0.01%
+243
New +$2.22K
MESO
1306
Mesoblast
MESO
$1.87B
$2K ﹤0.01%
105
MRVI icon
1307
Maravai LifeSciences
MRVI
$1.01B
$2K ﹤0.01%
490
ORIC icon
1308
Oric Pharmaceuticals
ORIC
$1.23B
$2K ﹤0.01%
249
PACB icon
1309
Pacific Biosciences
PACB
$432M
$2K ﹤0.01%
909
PRTA icon
1310
Prothena Corp
PRTA
$448M
$2K ﹤0.01%
195
PSNL icon
1311
Personalis
PSNL
$1.27B
$2K ﹤0.01%
200
-200
-50% -$1.75K
PSNY icon
1312
Polestar Automotive Holding UK
PSNY
$2.03B
$2K ﹤0.01%
+100
New +$2.09K
REPL icon
1313
Replimune Group
REPL
$449M
$2K ﹤0.01%
200
RGNX icon
1314
Regenxbio
RGNX
$615M
$2K ﹤0.01%
146
RIGL icon
1315
Rigel Pharmaceuticals
RIGL
$712M
$2K ﹤0.01%
40
-40
-50% -$1.51K
SIGA icon
1316
SIGA Technologies
SIGA
$240M
$2K ﹤0.01%
270
TBPH icon
1317
Theravance Biopharma
TBPH
$875M
$2K ﹤0.01%
115
-100
-47% -$1.66K
TRDA icon
1318
Entrada Therapeutics
TRDA
$226M
$2K ﹤0.01%
150
VGLT icon
1319
Vanguard Long-Term Treasury ETF
VGLT
$10.2B
$2K ﹤0.01%
29
-79
-73% -$4.5K
VNDA icon
1320
Vanda Pharmaceuticals
VNDA
$310M
$2K ﹤0.01%
191
VTYX
1321
DELISTED
Ventyx Biosciences
VTYX
$2K ﹤0.01%
+238
New +$1.78K
XLU icon
1322
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
$2K ﹤0.01%
52
+30
+136% +$1.33K
ZVRA icon
1323
Zevra Therapeutics
ZVRA
$575M
$2K ﹤0.01%
182
AVBP icon
1324
ArriVent BioPharma
AVBP
$1.4B
$2K ﹤0.01%
111
BIOA
1325
BioAge Labs
BIOA
$974M
$2K ﹤0.01%
+119
New +$1.05K

Similar funds

Daiwa Securities Group's Q4 2025 Portfolio in Review

As of Q4 2025, Daiwa Securities Group held 1,441 positions worth $31.3B, up 5.6% from $29.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group deployed $1.83B of net new capital in Q4 2025, opening 112 new positions and adding to 695 existing holdings. Its largest new stake was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $542M trimmed.

  • Daiwa Securities Group's largest Q4 2025 buy was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.
  • Daiwa Securities Group added most to Palantir in Q4 2025, an estimated $698M increase.
  • Daiwa Securities Group's biggest Q4 2025 reduction was ServiceNow, cutting an estimated $542M.
  • Daiwa Securities Group fully exited Eagle Materials in Q4 2025, selling an estimated $12.8M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $31.3B portfolio in Q4 2025.
  • Daiwa Securities Group opened 112 new positions and closed 81 in Q4 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $31.3B.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.